Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Potassium channel subfamily K members (KCNK), also known as two-pore-domain potassium channels (K2P), are a family of potassium ion channels that play a crucial role in setting and stabilizing the resting membrane potential in various cell types. These channels are characterized by their unique structure, comprising four transmembrane domains and two pore-forming loops per subunit, and their ability to allow passive movement of potassium ions across the cell membrane. They are widely expressed throughout multiple organ systems, including the central nervous system, cardiovascular system, gastrointestinal tract, and genitourinary system. Their activity is regulated by diverse factors such as oxygen tension, pH changes, mechanical stretch, temperature shifts, and G-protein-coupled receptor signaling pathways. Dysregulation or mutation of certain family members has been implicated in neurological disorders, cardiac arrhythmias, and hypertension.
Modulation of potassium ion flow across cell membranes, affecting membrane potential and cellular excitability.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium Channel Subfamily K Member (KCNK).